The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Single-cell Transcriptomics Uncover a Novel Role of Myeloid Cells and T-lymphocytes in the Fibrotic Microenvironment in Peyronie’s Disease
Open accessAbstract
Background Peyronie's disease (PD) is an acquired fibrotic disease affecting the penile tunica albuginea that can lead to curvature and deformities, shortening, and erectile dysfunction. Although immunological mechanisms have been suggested for the pathophysiology of PD, these have not been investigated using single-cell transcriptomics. Objective To investigate the immunological signature of plaques from PD patients using immunohistochemistry (IHC) and single-cell RNA sequencing (scRNA-Seq). Design, setting, and participants Tunica albuginea biopsy was performed in patients undergoing penile surgery for either PD (n = 12) or plication or penile cancer (control, n = 6). The inclusion criteria for PD patients were stable chronic disease (≥12 mo in duration) and no previous penile surgery or intralesional injection therapy. Outcome measurements and statistical analysis IHC was performed on surgical samples from ten patients with PD and five control subjects. An additional two PD and one control sample were used for scRNA-Seq (droplet-based; 10X Genomics). Cell clusters were visualised using heatmaps and t-distributed stochastic neighbour embedding plots (BioTuring v2.7.5). Results and limitations IHC revealed the presence of myeloid dendritic cells (DCs; CD68+, TLR4+, CD206+), cytotoxic T lymphocytes (CTLs; CD3+, CD8+), and B lymphocytes (CD20+) in PD plaques, which were absent in controls. scRNA-Seq yielded results for 3312 PD and 5658 control cells. Cell clusters contained fibroblasts (COL1A2+), myofibroblasts (COL1A2+, ACTA2+), smooth muscle cells (ACTA2+, DES+), endothelial cells (VWF+), myeloid cells (CD14+), T lymphocytes (CD3D+), and neutrophils (ALPL+). Myeloid cell subclustering showed infiltration of monocyte-derived cells; control tissue contained classical DCs and resident macrophages. Lymphocyte subclustering revealed mucosal-associated invariant T (MAIT) cells and CTLs in PD. Differential gene expression suggests an increase in inflammatory and immune responses in chronic PD. The study is limited by the small scRNA-seq sample size (n = 3) for IHC, mitigated by a larger cohort of historic paraffin-embedded samples (n = 15), which showed largely parallel findings. Owing to tissue stiffness and extracellular matrix adhesion, our single-cell yield was lower for PD than for the control sample. Conclusions Our data suggest that even in the chronic PD stage (painless and stable curvature) there is a sustained inflammatory reaction. While vascularisation and collagen production are elevated, the inflammation is driven by specialised monocyte-derived CTL and MAIT cells. These findings could uncover new avenues for medical treatment of PD. Patient summary We looked at the role of the immune system in patients suffering from Peyronie's disease, a condition causing shortening and curvature of the penis. We found that even in a stable, chronic stage of the disease, there is activation of the immune system. Our results suggest that there is potential for novel treatments for this condition.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Mutations or abnormal expression of the COL1A1 gene are associated with PD.
“Studies have shown that mutations or abnormal expression of the COL1A1 gene are associated with PD.”
From Research advances in Peyronie's disease: a comprehensive review on genomics, pathways, phenotypic manifestation, and therapeutic targets. (2024) · cites this paper as [19]
Genes involved in collagen synthesis, such as COL1A1, COL3A1, and MMP2, are associated with an increased risk of developing PD.
“Genes involved in collagen synthesis, such as COL1A1, COL3A1, and MMP2, have been found to be associated with an increased risk of developing PD.”
From Research advances in Peyronie's disease: a comprehensive review on genomics, pathways, phenotypic manifestation, and therapeutic targets. (2024) · cites this paper as [19]
In a stable, chronic stage of the disease, the immune system remains active.
“In a stable, chronic stage of the disease, the immune system remains active.19”
From Research advances in Peyronie's disease: a comprehensive review on genomics, pathways, phenotypic manifestation, and therapeutic targets. (2024) · cites this paper as [19]
Citations
Cites
Human dendritic cell subsets: an update
Collin, M., & Bigley, V. (2018) · Immunology · doi:10.1111/imm.12888 · Cited by 1,301
Proposal: Trauma as the Cause of the Peyronie's Lesion
Devine, C. J. J., Somers, K. D., Jordan, G. H., & Schlossberg, S. M. (1997) · Journal of Urology · doi:10.1016/s0022-5347(01)65361-8 · Cited by 381
Treatment of Idiopathic Pulmonary Fibrosis with Etanercept: An Exploratory, Placebo-controlled Trial
Raghu, G., Brown, K. K., Costabel, U., Cottin, V., du Bois, R. M., Lasky, J. A., Thomeer, M., Utz, J. P., Khandker, R. K., McDermott, L., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200709-1446oc · Cited by 370
The Chronology of Depression and Distress in Men with Peyronie's Disease
Nelson, C. J., Diblasio, C., Kendirci, M., Hellstrom, W., Guhring, P., & Mulhall, J. P. (2008) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2008.00895.x · Cited by 255
Mechanisms of Disease: new insights into the cellular and molecular pathology of Peyronie's disease
Gonzalez-Cadavid, N. F., & Rajfer, J. (2005) · Nature Clinical Practice Urology · doi:10.1038/ncpuro0201 · Cited by 168
Flagged first, then by citations
Research works printed but not linked: 25
- Al-Thakafi, 2016, Peyronie’s disease: a literature review on epidemiology, genetics, pathophysiology, diagnosis and work-up, Transl Androl Urol, 5, 280, 10.21037/tau.2016.04.05 · DOI
- Hatzichristodoulou, 2017, Contemporary review of grafting techniques for the surgical treatment of Peyronie’s disease, Sex Med Rev, 5, 544, 10.1016/j.sxmr.2017.01.006 · DOI
- Russo, 2018, Clinical efficacy of injection and mechanical therapy for Peyronie’s disease: a systematic review of the literature, Eur Urol, 74, 767, 10.1016/j.eururo.2018.07.005 · DOI
- Milenkovic, 2019, Simvastatin and the Rho-kinase inhibitor Y-27632 prevent myofibroblast transformation in Peyronie’s disease-derived fibroblasts via inhibition of YAP/TAZ nuclear translocation, BJU Int, 123, 703, 10.1111/bju.14638 · DOI · Paper page
- Milenkovic, 2019, Pathophysiology and future therapeutic perspectives for resolving fibrosis in Peyronie’s disease, Sex Med Rev, 7, 679, 10.1016/j.sxmr.2019.02.004 · DOI
- Ilg, 2019, Antifibrotic synergy between phosphodiesterase type 5 inhibitors and selective oestrogen receptor modulators in Peyronie’s disease models, Eur Urol, 75, 329, 10.1016/j.eururo.2018.10.014 · DOI
- Milenkovic, 2019, The mechanisms and potential of stem cell therapy for penile fibrosis, Nat Rev Urol, 16, 79, 10.1038/s41585-018-0109-7 · DOI
- Hinz, 2020, Evasion of apoptosis by myofibroblasts: a hallmark of fibrotic diseases, Nat Rev Rheumatol, 16, 11, 10.1038/s41584-019-0324-5 · DOI
- Hinz, 2007, The myofibroblast: one function, multiple origins, Am J Pathol, 170, 1807, 10.2353/ajpath.2007.070112 · DOI · Paper page
- Davis, 1997, The microscopic pathology of Peyronie’s disease, J Urol, 157, 282, 10.1016/S0022-5347(01)65360-6 · DOI
- Ralph, 1996, The immunological features of Peyronie’s disease, J Urol, 155, 159, 10.1016/S0022-5347(01)66582-0 · DOI
- Magee, 2002, Gene expression profiles in the Peyronie’s disease plaque, Urology, 59, 451, 10.1016/S0090-4295(01)01578-3 · DOI
- Assassi, 2015, Dissecting the heterogeneity of skin gene expression patterns in systemic sclerosis, Arthritis Rheumatol, 67, 3016, 10.1002/art.39289 · DOI
- Yang, 2013, Expression of cilium-associated genes defines novel molecular subtypes of idiopathic pulmonary fibrosis, Thorax, 68, 1114, 10.1136/thoraxjnl-2012-202943 · DOI
- Pendergrass, 2010, Limited systemic sclerosis patients with pulmonary arterial hypertension show biomarkers of inflammation and vascular injury, PLoS One, 5, 10.1371/journal.pone.0012106 · DOI
- Distler, 2019, Shared and distinct mechanisms of fibrosis, Nat Rev Rheumatol, 15, 705, 10.1038/s41584-019-0322-7 · DOI
- Land, 2015, The role of damage-associated molecular patterns (DAMPs) in human diseases part II: DAMPs as diagnostics, prognostics and therapeutics in clinical medicine, Sultan Qaboos Univ Med J, 15, e157, 10.18295/2075-0528.1676 · DOI
- Kapellos, 2019, Human monocyte subsets and phenotypes in major chronic inflammatory diseases, Front Immunol, 10, 2035, 10.3389/fimmu.2019.02035 · DOI
- Tang-Huau, 2018, Human in vivo-generated monocyte-derived dendritic cells and macrophages cross-present antigens through a vacuolar pathway, Nat Commun, 9, 2570, 10.1038/s41467-018-04985-0 · DOI
- Zaba, 2009, Psoriasis is characterized by accumulation of immunostimulatory and Th1/Th17 cell-polarizing myeloid dendritic cells, J Invest Dermatol, 129, 79, 10.1038/jid.2008.194 · DOI
- Liao, 2017, Peritoneal macrophage heterogeneity is associated with different peritoneal dialysis outcomes, Kidney Int, 91, 1088, 10.1016/j.kint.2016.10.030 · DOI
- Ferenbach, 2008, Macrophages and dendritic cells: what is the difference?, Kidney Int, 74, 5, 10.1038/ki.2008.189 · DOI
- Guilliams, 2014, Dendritic cells, monocytes and macrophages: a unified nomenclature based on ontogeny, Nat Rev Immunol, 14, 571, 10.1038/nri3712 · DOI
- Park, 2019, Differences in the molecular signatures of mucosal-associated invariant T cells and conventional T cells, Sci Rep, 9, 7094, 10.1038/s41598-019-43578-9 · DOI
- Toubal, 2019, Mucosal-associated invariant T cells and disease, Nat Rev Immunol, 19, 643, 10.1038/s41577-019-0191-y · DOI · Paper page
Cited by
Sorted by citations
Molecular Mechanisms and Risk Factors Related to the Pathogenesis of Peyronie’s Disease
Mitsui, Y., Yamabe, F., Hori, S., Uetani, M., Kobayashi, H., Nagao, K., & Nakajima, K. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241210133 · Cited by 32
“that used immunohistochemistry and scRNASeq indicated the possibility of a sustained inflammatory reaction even in the chronic PD stage [99].”
Giagulli, V. A., Lisco, G., Tullio, A. D., Guastamacchia, E., Triggiani, V., & Jirillo, E. (2023) · Sexual Medicine Reviews · doi:10.1093/sxmrev/qead055 · Cited by 24
Main Pathological Changes of Benign Ureteral Strictures
Tan, J.-W., Yu, Z.-Y., Ling, X., Qiu, G., Yang, X., Tang, Y., Yang, D., Yang, M., & Gao, F. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.916145 · Cited by 19
“Meanwhile, the inflammation driven by specialized monocyte-derived contributes to Peyronie’s disease (18).”
BackgroundThe contribution of the immune system to genitourinary fibrosis
Doersch, K. M., Barnett, D., Chase, A., Johnston, D., & Gabrielsen, J. S. (2022) · Experimental Biology and Medicine · doi:10.1177/15353702221090872 · Cited by 15
Pathological Significance of Macrophages in Erectile Dysfunction Including Peyronie’s Disease
Miyata, Y., Matsuo, T., Nakamura, Y., Mitsunari, K., Ohba, K., & Sakai, H. (2021) · Biomedicines · doi:10.3390/biomedicines9111658 · Cited by 16
Chi, J., Bi, W., Lou, K., Ma, J., Wu, J., & Cui, Y. (2024) · Sexual Medicine Reviews · doi:10.1093/sxmrev/qeae006 · Cited by 14
Fridayana, F. R., Rho, B., Yin, G., & Ryu, J. (2025) · Translational Andrology and Urology · doi:10.21037/tau-2025-318 · Cited by 4
“Recent scRNA-seq profiling of Peyronie’s disease (PD) tissue (49) revealed FB subpopulations enriched in fibrotic and inflammatory gene signatures, including high expression of COL1A1 , actin, alpha 2, smooth muscle ( ACTA2 ), and IL - 6 .”
Lou, K., Mao, Q., Chi, J., Zhang, J., Guo, H., Wu, J., & Cui, Y. (2025) · Open Research (University of Surrey) · doi:10.1002/viw.20250011 · Cited by 3
Cui, Y., Chen, L., Wang, X., Yu, L., & Wu, J. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1019358 · Cited by 4
“Studies have confirmed the presence of CD8 cytotoxic T cells, B cells, and dendritic cells, as well as more specialized monocyte-derived CTL and MAIT cells in Peyronie’s plaques, which stimulate an inflammatory response (Milenkovic et al., 2021).”
BackgroundRao, W.-T., Jiang, S., Shen, Y.-H., Wang, Y.-H., Liu, S., Tang, J.-D., & Xing, J. (2023) · Ultrasound in Medicine and Biology · doi:10.1016/j.ultrasmedbio.2023.07.010 · Cited by 2
Benign Uroandrological Ecosystem: A Thorough Overview from Single-Cell and Spatial Transcriptomics
Xie, Y.-D., Ye, J.-J., Wang, J., Tuo, Z.-T., Wu, R.-C., Wusiman, D., Cho, W. C., Lyu, Z., Zhang, Q., Feng, D.-C., et al. (2026) · Research · doi:10.34133/research.1438
“[ 85 ].”
InfluentialLi, Z., Hu, H., Zheng, X., Liu, B., Zhao, L., Han, Z., Zhou, Z., Xu, J., Yin, Y., & Tang, Y. (2025) · Sexual Medicine · doi:10.1093/sexmed/qfaf082
Metadata
- Authors
- Milenkovic, U., Boeckx, B., Lambrechts, D., Janky, R., Hatzichristodoulou, G., van Renterghem, K., Gevaert, T., Cellek, S., Bivalacqua, T. J., De Ridder, D., & Albersen, M.
- Affiliations
- VIB-KU Leuven Center for Cancer Biology (BE)
- Martha-Maria Hospital (DE)
- Jessa Hospital (BE)
- KU Leuven (BE)
- Anglia Ruskin University (GB)
- Johns Hopkins University (US)
- Universitair Ziekenhuis Leuven (BE)
- ORCID
- Venue
- European Urology Focus
- Publisher
- Elsevier BV
- Published
- 2022-05
- Volume
- 8
- Issue
- 3
- Pages
- 814-828
- ISSN
- 2405-4569 (ISSN-L)
- OpenAlex
- W3157098491
- Cited by
- 14
- References
- 32
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 1 · 2023: 3 · 2022: 4
- FWCI
- 1.70
- Type
- journal article
- Language
- en
- Open access
- green
- lirias.kuleuven.be
- Licence
- Locations
- European Urology Focus (publishedVersion)
- PubMed (publishedVersion)
- Anglia Ruskin Research Online (Anglia Ruskin University) (acceptedVersion)
- Lirias (KU Leuven) (submittedVersion, other-oa)
- Document Server@UHasselt (UHasselt) (submittedVersion)
- Figshare (submittedVersion, cc-by-nc-nd)
- Funders
- European Society for Sexual Medicine
- Topics
- Health Sciences › Medicine › Rheumatology › Dupuytren's Contracture and Treatments
- Health Sciences › Medicine › Urology › Urological Disorders and Treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Sexual function and dysfunction studies
- Keywords
- Peyronie's disease, tunica albuginea, fibrosis, myeloid cells, T cells, cytotoxic T lymphocytes, mucosal-associated invariant T cells, monocyte-derived cells, chronic inflammation, immune microenvironment, collagen synthesis, vascularization, penile curvature, penile cancer, plication, single-cell RNA sequencing, immunohistochemistry, penile biopsy
- MeSH terms
- Humans, Male, Penile Induration, T-Lymphocytes, Myeloid Cells, Endothelial Cells, Transcriptome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review